Demant Long Term Debt 2012-2025 | WILYY
Demant long term debt from 2012 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- Demant long term debt for the quarter ending June 30, 2025 was $1.811B, a 291.76% increase year-over-year.
- Demant long term debt for 2024 was $1.811B, a 22.6% increase from 2023.
- Demant long term debt for 2023 was $1.477B, a 71.03% increase from 2022.
- Demant long term debt for 2022 was $0.863B, a 94.18% increase from 2021.
|
Demant Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $1,811 |
| 2023 | $1,477 |
| 2022 | $863 |
| 2021 | $445 |
| 2020 | $536 |
| 2019 | $377 |
| 2018 | $343 |
| 2017 | $350 |
| 2016 | $291 |
| 2015 | $310 |
| 2014 | |
| 2013 | $14 |
| 2012 | $13 |
| 2011 | $189 |
|
Demant Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,811 |
| 2023-12-31 | $1,477 |
| 2023-06-30 | $1,119 |
| 2022-12-31 | $863 |
| 2022-06-30 | $462 |
| 2021-12-31 | $445 |
| 2021-06-30 | $547 |
| 2020-12-31 | $536 |
| 2020-06-30 | $358 |
| 2019-12-31 | $377 |
| 2019-06-30 | $189 |
| 2018-12-31 | $343 |
| 2018-06-30 | $256 |
| 2017-12-31 | $350 |
| 2017-06-30 | $290 |
| 2016-12-31 | $291 |
| 2016-06-30 | $306 |
| 2015-12-31 | $310 |
| 2014-06-30 | $12 |
| 2013-12-31 | $14 |
| 2013-06-30 | $12 |
| 2012-12-31 | $13 |
| 2012-06-30 | $47 |
| 2011-12-31 | $189 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.372B | $3.252B |
| Demant A/S is engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The company's business area consists of Hearing Devices, Hearing Implants, Diagnostic Instruments and Personal Communication. Demant A/S, formerly known as William Demant Holding A/S, is based in Smorum, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $217.359B | 25.05 |
| EssilorLuxottica (ESLOY) | France | $151.069B | 0.00 |
| Boston Scientific (BSX) | United States | $138.964B | 31.78 |
| Stryker (SYK) | United States | $137.439B | 27.29 |
| Medtronic (MDT) | Ireland | $126.586B | 17.54 |
| Medline (MDLN) | United States | $57.028B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.992B | 0.00 |
| Agilent Technologies (A) | United States | $41.368B | 26.15 |
| GE HealthCare Technologies (GEHC) | United States | $38.856B | 18.58 |
| ResMed (RMD) | United States | $37.873B | 26.21 |
| Koninklijke Philips (PHG) | Netherlands | $28.984B | 18.93 |
| Terumo (TRUMY) | Japan | $21.172B | 23.83 |
| Insulet (PODD) | United States | $19.900B | 61.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.686B | 11.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.986B | 0.00 |
| Baxter (BAX) | United States | $10.199B | 8.23 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.585B | 30.87 |
| Lantheus Holdings (LNTH) | United States | $4.350B | 13.25 |
| BillionToOne (BLLN) | United States | $4.319B | 0.00 |
| Envista Holdings (NVST) | United States | $3.979B | 22.83 |
| ICU Medical (ICUI) | United States | $3.666B | 23.28 |
| Haemonetics (HAE) | United States | $3.545B | 15.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.115B | 14.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.333B | 15.00 |
| Perrigo (PRGO) | Ireland | $2.045B | 5.12 |
| Neogen (NEOG) | United States | $2.043B | 44.71 |
| LeMaitre Vascular (LMAT) | United States | $1.939B | 39.02 |
| Curaleaf Holdings (CURLF) | Canada | $1.866B | 0.00 |
| AtriCure (ATRC) | United States | $1.858B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.734B | 76.00 |
| Phibro Animal Health (PAHC) | United States | $1.616B | 16.14 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.471B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.427B | 20.67 |
| Kestra Medical Technologies (KMTS) | United States | $1.302B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.170B | 347.00 |
| Capricor Therapeutics (CAPR) | United States | $1.133B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.112B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.007B | 0.00 |
| Omeros (OMER) | United States | $0.927B | 0.00 |
| Valneva SE (VALN) | France | $0.893B | 0.00 |
| InMode (INMD) | Israel | $0.887B | 10.03 |
| CeriBell (CBLL) | United States | $0.851B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.573B | 15.55 |
| Cerus (CERS) | United States | $0.526B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.483B | 0.00 |
| Brainsway (BWAY) | Israel | $0.461B | 78.50 |
| Canopy Growth (CGC) | Canada | $0.450B | 0.00 |
| SNDL (SNDL) | Canada | $0.428B | 0.00 |
| Quanterix (QTRX) | United States | $0.343B | 0.00 |
| Evolus (EOLS) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 22.06 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.241B | 142.00 |
| Sanuwave Health (SNWV) | United States | $0.241B | 0.00 |
| High Tide (HITI) | Canada | $0.228B | 0.00 |
| Organigram Global (OGI) | Canada | $0.218B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.206B | 0.00 |
| Accendra Health (ACH) | United States | $0.200B | 2.00 |
| Vireo Growth (VREOF) | United States | $0.197B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.189B | 16.64 |
| Quipt Home Medical (QIPT) | United States | $0.159B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.145B | 0.00 |
| Apyx Medical (APYX) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.77 |
| Exagen (XGN) | United States | $0.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.113B | 0.00 |
| Biote (BTMD) | United States | $0.109B | 4.76 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.46 |
| Nephros (NEPH) | United States | $0.047B | 33.92 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.74 |
| Jin Medical (ZJYL) | China | $0.026B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |